We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SKWD:NASDAQSkyward Specialty Insurance Group, Inc. Analysis

Data as of 2026-09-01 - not real-time

$57.71

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Skyward Specialty Insurance Group, Inc. is neutral at $57.71, with no clear ordering between short and long averages. Over a rolling month the price has lost 4.0%. With RSI at 46.8 the momentum picture is neutral, alongside a bearish MACD signal. Watch $54.02 as support and $65.69 as the nearer resistance level.
The shares look undervalued, trading on 13.4 times earnings below a sector average of 16.8. Sell-side targets cluster 22.2% above the current quote. Revenue is growing at 53.0% on a 10.8% profit margin.
Risk comes out at 5 of a possible 10, a moderate reading. With 30-day volatility of 35.7%, a beta of 0.06 and a maximum drawdown of 20.8%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on buy — conviction 6 out of 10.

Top Market Events

Specialty insurance provider Skyward Specialty Insurance NASDAQ:SKWD reported in Q2 CY2026, with sales up 53% year on...LONDON, July 21, 2026 GLOBE NEWSWIRE -- Apollo, a Skyward Group company Nasdaq: SKWD , the innovation inspired...HOUSTON, Aug. 04, 2026 GLOBE NEWSWIRE -- Skyward Specialty Insurance Group, Inc. Nasdaq: SKWD "Skyward Group" or the...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 4/10

Key Factors

  • Trading above the 200-day average of 49.71
  • MACD momentum is negative
  • Maximum drawdown of 20.8%

Medium Term

1–3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 13.4 versus sector average of 16.8
  • Trading above the 200-day average of 49.71
  • Analyst targets imply +22.2% versus the current price

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 13.4 versus sector average of 16.8
  • Analyst targets imply +22.2% versus the current price
  • Revenue growth of +53.0%

Key Metrics & Analysis

Financial Health

Revenue Growth53.00%
Profit Margin10.84%
P/E Ratio13.4
ROE17.34%
ROA3.10%
Debt/Equity34.49
P/B Ratio2.0
Op. Cash Flow$407.3M
Free Cash Flow$-592195264
Industry P/E16.8

Technical Analysis

TrendNeutral
RSI46.8
Support$54.02
Resistance$65.69
MA 20$59.22
MA 50$59.36
MA 200$49.71
MACDBearish
VolumeDecreasing
Fear & Greed Index93.07

Valuation

Fair Value$248.43
Target Price$70.55
Upside/Downside22.24%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.06
Volatility35.74%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.